TCTR20240422011RecruitingNot Applicable
Efficacy and Safety of High Dose Intravenous Iron for Correcting Anemia and Reducing Blood Transfusion in Patient Undergoing Hysterectomy: Retrospective Cohort Study
Faculty of Medicine Khon Kaen University Research Fund0 sites124 target enrollmentStarted: April 22, 2024Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Recruiting
- Sponsor
- Enrollment
- 124
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 20 Years to N/A (No limit) (—)
- Sex
- Female
Inclusion Criteria
- •1. Patients diagnosed with uterine tumor and/or abnormal vaginal bleeding such as Leiomyoma, Adenomyosis, Endometrial hyperplasia, heavy menstrual bleeding, etc.
- •2. Patients who had hysterectomy at Srinakarind Hospital during 1 January 2020 to 31 August 2023.
- •3. Patients older than or equal to 20 years old.
- •4. Patients with blood concentration values less than 12 (Hb < 12 g/dL)
Exclusion Criteria
- •1.Patients who have been diagnosed with cancer
- •2.Patients who have undergone surgery and lost more than 1,000 ml of blood
- •3.Patients with chronic diseases such as thalassemia anemia, blood-dependent type
- •4.Patients with anemia due to abnormal bone marrow function
- •5.Patients who receive chemotherapy
- •6.Patients with Ferritin > 800 ng/mL
- •7.Patients with transferrin saturation (TSAT) more than and equal 50%
- •8.Patients with incomplete or missing records and medical history
Investigators
Similar Trials
Recruiting
Not Applicable
Efficacy and Safety of High Dose Intravenous Iron for Treatment Iron Deficiency Anemia in Gynecologic Malignancy Disease: Retrospective Cohort StudyPetient who has Iron deficiency anemia in gynecologic malignancy diseaseIron deficiency anemia, iv iron, gynecologic malignancy diseaseTCTR20230815001Faculty of Medicine, KhonKaen university108
Not yet recruiting
Not Applicable
Intravenous single dose iron infusioCTRI/2021/05/033579DST Chandigarh
Completed
Phase 3
Randomized controlled trial of the Effect of intraVenous iron on Anaemia in Malawian Pregnant women in their third trimester: REVAMP-TTAnaemiaIron-deficiencyHypophosphataemiaFoetal anaemiaInfectionChild developmentMaternal depressionBlood - AnaemiaMental Health - DepressionReproductive Health and Childbirth - Other reproductive health and childbirth disordersInfection - Other infectious diseasesACTRN12621001239853Training and Research Unit of Excellence (TRUE), Malawi590
Recruiting
Phase 3
Efficacy and Demonstration of IntraVenous Iron for Anaemia in pregnancy (EDIVA)AnaemiaIron deficiencyMaternal depressionLow birthweightPrematuritysmall for gestational ageBlood - AnaemiaReproductive Health and Childbirth - Fetal medicine and complications of pregnancyDiet and Nutrition - Other diet and nutrition disordersMental Health - DepressionACTRN12621000968875International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b)900
Not yet recruiting
Phase 2
IV iron infusion therapy in patients with persistent paiACTRN12622000412730Metro North Health Services Royal Brisbane and Women's Hospital160